65,437 trials
Influenza Disease; Flu
Primary: Geometric Mean Titers (GMT) After 1 Dose of Cell-culture-derived Vaccine (cTIV) or Egg-derived Vaccine (eTIV_f), Using the ANOVA Method. — 259; 306; 181; 320 Titer
Colonoscopy
Primary: The Ottawa Scale Score of Patients Who Had Successfully Completed the Colonoscopy Examination After Having Completed the Study Bowel Preparation — 4.73; 4.91 units on a…
Allergic Rhinitis · Upper Respiratory Infection
Primary: AUC of Doxylamine — 461.9; 810.1; 827.0 ng*h/mL
Streptococcus Pneumoniae · Haemophilus Influenzae
Primary: Number of Subjects With Any Solicited Local and General Symptoms — 15; 16; 4; 10 Subjects
Nicotine Dependence
Primary: Change in Craving for Cigarettes After Smoking Cues Versus Neutral Cues Using a Repeated Measure Design. — -.18; .12; 1.29 units on a scale — p=0.014
Arthritis, Rheumatoid
Primary: Percentage of Participants Achieving American College of Rheumatology 20% (ACR20) Response at Week 12 — 64.3; 77.8; 96.3; 80.8 Percentage of Participants
Breast Cancer
Primary: The Safety and Tolerability of Protocol Treatment, Defined as the Percentage of Patients Experiencing Severe or Life-threatening Side Effects Per CTCAE Version 3.0. — 40…
Primary Immunodeficiency (PID)
Primary: Total Serum IgG Trough Levels — 7.97 g/L
Diabetes Mellitus, Non-Insulin-Dependent
Primary: Composite of the First Occurrence of Cardiovascular (CV) Death, Nonfatal Myocardial Infarction (MI) or Nonfatal Stroke — 1041; 1013; 484; 476 participants — p=0.6273
Diverticulitis
Primary: Percent of Subjects Without Recurrence of Diverticulitis — 62.2; 62.9; 52.7; 64.6 percentage of subjects — p=0.047
Breast Cancer
Primary: Pathological Complete Response After Preoperative Therapy With Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in Patients With HER-2 Positive Early Breast…
Breast Cancer
Primary: Incidence of Fatty Liver Disease — 9; 53; 15; 66 participants
Primary Immune Deficiency
Primary: Annualized Rate of Serious Bacterial Infection (Intention-to-Treat Population) — 0.06 infections per subject year
Ovarian Carcinoma · Peritoneal Neoplasms
Primary: Tumor Response Type: CR, PR, SD or PD — 1; 4; 9; 6 Participants
Hepatitis B
Primary: Number of Hepatitis B (HB)-Specific Cluster of Differentiation 4 (CD4+) T Cells . — 1345; 1257; 647; 391 HB-CD4+ T cells (per million cells)